Abstract
We previously reported that Frizzled homologue 10 (FZD10), a member of the Wnt signal receptor family, was highly and specifically upregulated in synovial sarcoma and played critical roles in its cell survival and growth. We here report a possible molecular mechanism of the FZD10 signaling in synovial sarcoma cells. We found a significant enhancement of phosphorylation of the Dishevelled (Dvl)2/Dvl3 complex as well as activation of the Rac1–JNK cascade in synovial sarcoma cells in which FZD10 was overexpressed. Activation of the FZD10–Dvls–Rac1 pathway induced lamellipodia formation and enhanced anchorage-independent cell growth cells. FZD10 overexpression also caused the destruction of the actin cytoskeleton structure, probably through the downregulation of the RhoA activity. Our results have strongly implied that FZD10 transactivation causes the activation of the non-canonical Dvl–Rac1–JNK pathway and plays critical roles in the development/progression of synovial sarcomas.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Aepfelbacher M, Essler M, Huber E, Czech A, Weber PC . (1996). Rho is a negative regulator of human monocyte spreading. J Immunol 157: 5070–5075.
Angers S, Thorpe CJ, Biechele TL, Goldenberg SJ, Zheng N, MacCoss MJ et al. (2006). The KLHL12-Cullin-3 ubiquitin ligase negatively regulates the Wnt-β–catenin pathway by targeting Dishevelled for degradation. Nat Cell Biol 8: 348–357.
Bain J, Plater L, Elliott M, Shpiro N, Hastie CJ, McLauchlan H et al. (2007). The selectivity of protein kinase inhibitors: a further update. Biochem J 408: 297–315.
Brett D, Whitehouse S, Antonson P, Shipley J, Cooper C, Goodwin G . (1997). The SYT protein involved in the t(X;18) synovial sarcoma translocation is a transcriptional activator localised in nuclear bodies. Hum Mol Genet 6: 1559–1564.
Bryja V, Schulte G, Arenas E . (2007a). Wnt-3a utilizes a novel low dose and rapid pathway that does not require casein kinase 1-mediated phosphorylation of Dvl to activate β-catenin. Cell Signal 19: 610–616.
Bryja V, Schulte G, Rawal N, Grahn A, Arenas E . (2007b). Wnt-5a induces Dishevelled phosphorylation and dopaminergic differentiation via a CK1-dependent mechanism. J Cell Sci 120: 586–595.
Capelluto DG, Kutateladze TG, Habas R, Finkielstein CV, He X, Overduin M . (2002). The DIX domain targets disheveled to actin stress fibres and vesicular membranes. Nature 419: 726–729.
Cheng TL, Symons M, Jou TS . (2004). Regulation of anoikis by Cdc42 and Rac1. Exp Cell Res 295: 497–511.
Clark J, Rocques PJ, Crew AJ, Gill S, Shipley J, Chan AM et al. (1994). Identification of novel genes, SYT and SSX, involved in the t(X;18)(p11.2;q11.2) translocation found in human synovial sarcoma. Nat Genet 7: 502–508.
Coindre JM, Pelmus M, Hostein I, Lussan C, Bui BN, Guillou L . (2003). Should molecular testing be required for diagnosing synovial sarcoma? A prospective study of 204 cases. Cancer 98: 2700–2707.
Coso OA, Chiariello M, Yu JC, Teramoto H, Crespo P, Xu N et al. (1995). The small GTP-binding proteins Rac1 and Cdc42 regulate the activity of the JNK/SAPK signaling pathway. Cell 81: 1137–1146.
Endo Y, Wolf V, Muraiso K, Kamijo K, Soon L, üren A et al. (2005). Wnt-3a-dependent cell motility involves RhoA activation and is specifically regulated by Dishevelled-2. J Biol Chem 280: 777–786.
Frisch SM, Screaton RA . (2001). Anoikis mechanisms. Curr Opin Cell Biol 13: 555–562.
Fukukawa C, Hanaoka H, Nagayama S, Tsunoda T, Toguchida J, Endo K et al. (2008). Radioimmunotherapy of human synovial sarcoma using a monoclonal antibody against FZD10. Cancer Sci 99: 432–440.
González-Sancho JM, Brennan KR, Castelo-Soccio LA, Brown AM . (2004). Wnt proteins induce Dishevelled phosphorylation via an LRP5/6-independent mechanism, irrespective of their ability to stabilize β-catenin. Mol Cell Biol 24: 4757–4768.
Habas R, Dawid IB, He X . (2003). Coactivation of Rac and Rho by Wnt/Frizzled signaling is required for vertebrate gastrulation. Genes Dev 17: 295–309.
Habu S, Okamoto E, Toyosaka A, Nakai Y, Takeuchi M . (1998). Synovial sarcoma of the esophagus: report of a case. Surg Today 28: 401–404.
Hall A . (1998). Rho GTPases and the actin cytoskeleton. Science 279: 509–514.
Hamel M, Kanyi D, Cipolle MD, Lowe-Krentz L . (2006). Active stress kinases in proliferating endothelial cells associated with cytoskeletal structures. Endothelium 13: 157–170.
Hino S, Michiue T, Asashima M, Kikuchi A . (2003). Casein kinase Iɛ enhances the binding of Dvl-1 to Frat-1 and is essential for Wnt-3a-induced accumulation of β-catenin. J Biol Chem 278: 14066–14073.
Hiraga H, Nojima T, Isu K, Yamashiro K, Yamawaki S, Nagashima K . (1999). Histological and molecular evidence of synovial sarcoma of bone. A case report. J Bone Joint Surg Am 81: 558–563.
Hosono T, Hironaka M, Kobayashi A, Yamasawa H, Bando M, Ohno S et al. (2005). Primary pulmonary synovial sarcoma confirmed by molecular detection of SYT-SSX1 fusion gene transcripts: a case report and review of the literature. Jpn J Clin Oncol 35: 274–279.
Kinoshita N, Iioka H, Miyakoshi A, Ueno N . (2003). PKCδ is essential for Dishevelled function in a noncanonical Wnt pathway that regulates Xenopus convergent extension movements. Genes Dev 17: 1663–1676.
Kishida S, Yamamoto H, Kikuchi A . (2004). Wnt-3a and Dvl induce neurite retraction by activating Rho-associated kinase. Mol Cell Biol 24: 4487–4501.
Koike J, Takagi A, Miwa T, Hirai M, Terada M, Katoh M . (1999). Molecular cloning of Frizzled-10, a novel member of the Frizzled gene family. Biochem Biophys Res Commun 262: 39–43.
Lim FL, Soulez M, Koczan D, Thiesen HJ, Knight JC . (1998). A KRAB-related domain and a novel transcription repression domain in proteins encoded by SSX genes that are disrupted in human sarcomas. Oncogene 17: 2013–2018.
McGilbray TT, Schulz TK . (2003). Clinical picture: primary cardiac synovial sarcoma. Lancet Oncol 4: 283.
Minden A, Lin A, Claret FX, Abo A, Karin M . (1995). Selective activation of the JNK signaling cascade and c-Jun transcription activity by the small GTPases Rac and Cdc42Hs. Cell 81: 1147–1157.
Nagayama S, Fukukawa C, Katagiri T, Okamoto T, Aoyama T, Oyaizu N et al. (2005). Therapeutic potential of antibodies against FZD10, a cell-surface protein, for synovial sarcomas. Oncogene 24: 6201–6212.
Nagayama S, Katagiri T, Tsunoda T, Hosaka T, Nakashima Y, Araki N et al. (2002). Genome-wide analysis of gene expression in synovial sarcomas using a cDNA microarray. Cancer Res 62: 5859–5866.
Nielsen TO, West RB, Linn SC, Alter O, Knowling MA, O'Connell JX et al. (2002). Molecular characterisation of soft tissue tumours: a gene expression study. Lancet 359: 1301–1307.
Nunnally AP, Parr BA . (2004). Analysis of Fz10 expression in mouse embryos. Dev Genes Evol 214: 144–148.
Ochi N, Uozumi M, Doi K, Tanimoto H, Ohbayashi C, Inagaki H et al. (2004). Synovial sarcoma of the neck. ORL J Otorhinolaryngol Relat Spec 66: 42–45.
Otto IM, Raabe T, Rennefahrt UE, Bork P, Rapp UR, Kerkhoff E . (2000). The p150-Spir protein provides a link between c-Jun N-terminal kinase function and actin reorganization. Curr Biol 10: 345–348.
Paterson HF, Self AJ, Garrett MD, Just I, Aktories K, Hall A . (1990). Microinjection of recombinant p21rho induces rapid changes in cell morphology. J Cell Biol 111: 1001–1007.
Rena G, Bain J, Elliott M, Cohen P . (2004). D4476, a cell-permeant inhibitor of CK1, suppresses the site-specific phosphorylation and nuclear exclusion of FOXO1a. EMBO R 5: 60–65.
Ridley AJ, Paterson HF, Johnston CL, Diekmann D, Hall A . (1992). The small GTP-binding protein rac regulates growth factor-induced membrane ruffling. Cell 70: 401–410.
Rosso SB, Sussman D, Wynshaw-Boris A, Salinas PC . (2005). Wnt signaling through Dishevelled, Rac and JNK regulates dendritic development. Nat Neurosci 8: 34–42.
Rothbächer U, Laurent MN, Deardorff MA, Klein PS, Cho KW, Fraser SE . (2000). Dishevelled phosphorylation, subcellular localization and multimerization regulate its role in early embryogenesis. EMBO J 19: 1010–1022.
Shannon BA, Murch A, Cohen RJ . (2005). Primary renal synovial sarcoma confirmed by cytogenetic analysis: a lesion distinct from sarcomatoid renal cell carcinoma. Arch Pathol Lab Med 129: 238–240.
Szuhai K, Knijnenburg J, Ijszenga M, Tanke HJ, Baatenburg de Jong RJ, Bas Douwes Dekker P et al. (2004). Multicolor fluorescence in situ hybridization analysis of a synovial sarcoma of the larynx with a t(X;18)(p11.2;q11.2) and trisomies 2 and 8. Cancer Genet Cytogenet 153: 48–52.
Segal NH, Pavlidis P, Antonescu CR, Maki RG, Noble WS, DeSantis D et al. (2003). Classification and subtype prediction of adult soft tissue sarcoma by functional genomics. Am J Pathol 163: 691–700.
Soulez M, Saurin AJ, Freemont PS, Knight JC . (1999). SSX and the synovial-sarcoma-specific chimaeric protein SYT-SSX co-localize with the human Polycomb group complex. Oncogene 18: 2739–2746.
Turc-Carel C, Dal Cin P, Limon J, Li F, Sandberg AA . (1986). Translocation X;18 in synovial sarcoma. Cancer Genet Cytogenet 23: 93.
Wang Z, Shu W, Lu MM, Morrisey EE . (2005). Wnt7b activates canonical signaling in epithelial and vascular smooth muscle cells through interactions with Fzd1, Fzd10, and LRP5. Mol Cell Biol 25: 5022–5030.
Wechezak AR, Coan DE . (2005). Dvl2 silencing in postdevelopmental cells results in aberrant cell membrane activity and actin disorganization. J Cell Physiol 202: 867–873.
Weiss SW, Goldblum JR . (2001). Enzinger and Weiss's Soft Tissue Tumors, 4th edn, Mosby: St Louis.
Wharton Jr KA . (2003). Runnin' with the Dvl: proteins that associate with Dsh/Dvl and their significance to Wnt signal transduction. Dev Biol 253: 1–17.
Wiggan O, Hamel PA . (2002). Pax3 regulates morphogenetic cell behavior in vitro coincident with activation of a PCP/non-canonical Wnt-signaling cascade. J Cell Sci 115: 531–541.
Williams DH, Hua VN, Chowdhry AA, Laskin WB, Kalapurakal JA, Dumanian GA et al. (2004). Synovial sarcoma of the prostate. J Urol 171: 2376.
Acknowledgements
We thank Dr Ryo Takata for statistical analysis, and Ms Kie Naito, Ms Yoshiko Fujisawa, Ms Akiko Konuma, Ms Aya Sasaki and Ms Kyoko Kijima for excellent technical assistance.
Author information
Authors and Affiliations
Corresponding author
Additional information
Supplementary Information accompanies the paper on the Oncogene website (http://www.nature.com/onc)
Rights and permissions
About this article
Cite this article
Fukukawa, C., Nagayama, S., Tsunoda, T. et al. Activation of the non-canonical Dvl–Rac1–JNK pathway by Frizzled homologue 10 in human synovial sarcoma. Oncogene 28, 1110–1120 (2009). https://doi.org/10.1038/onc.2008.467
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/onc.2008.467
Keywords
This article is cited by
-
Hsa-miR-143-3p inhibits Wnt-β-catenin and MAPK signaling in human corneal epithelial stem cells
Scientific Reports (2022)
-
Induction of RAC1 protein translation and MKK7/JNK-dependent autophagy through dicer/miR-145/SOX2/miR-365a axis contributes to isorhapontigenin (ISO) inhibition of human bladder cancer invasion
Cell Death & Disease (2022)
-
Molecular subtypes based on DNA methylation predict prognosis in lung squamous cell carcinoma
BMC Cancer (2021)
-
Synovial Sarcoma: A Complex Disease with Multifaceted Signaling and Epigenetic Landscapes
Current Oncology Reports (2020)
-
The hedgehog and Wnt/β-catenin system machinery mediate myofibroblast differentiation of LR-MSCs in pulmonary fibrogenesis
Cell Death & Disease (2018)